Wird geladen...
Whole Chromosome alterations predict survival in high risk neuroblastoma without MYCN amplification
PURPOSE: Patients with stage 4 neuroblastoma over the age of 500 days without MYCN amplification have a survival rate of less than 30% and there are currently no reliable means of predicting which of these patients will survive or succumb from the disease. The goal of this study is to develop a DNA...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2008
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2535913/ https://ncbi.nlm.nih.gov/pubmed/18765546 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-07-4461 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|